REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Jul 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-07-01

Reporting Person: RYAN ARTHUR F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-01	Common Stock	S	2	$555.47	Disposed	23589	Direct
2021-07-01	Common Stock	S	4	$556.71	Disposed	23585	Direct
2021-07-01	Common Stock	S	1	$557.75	Disposed	23584	Direct
2021-07-01	Common Stock	S	2	$559.78	Disposed	23582	Direct
2021-07-01	Common Stock	S	2	$560.62	Disposed	23580	Direct
2021-07-01	Common Stock	S	6	$561.8	Disposed	23574	Direct
2021-07-01	Common Stock	S	10	$562.48	Disposed	23564	Direct
2021-07-01	Common Stock	S	16	$563.4	Disposed	23548	Direct
2021-07-01	Common Stock	S	6	$564.71	Disposed	23542	Direct
2021-07-01	Common Stock	S	13	$565.44	Disposed	23529	Direct
2021-07-01	Common Stock	S	12	$566.42	Disposed	23517	Direct
2021-07-01	Common Stock	S	13	$567.56	Disposed	23504	Direct
2021-07-01	Common Stock	S	13	$568.43	Disposed	23491	Direct

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 4 shares of Company stock on July 1, 2021 at prices ranging from $556.60 to $556.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 2 shares of Company stock on July 1, 2021 at prices ranging from $560.43 to $560.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 6 shares of Company stock on July 1, 2021 at prices ranging from $561.57 to $561.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 10 shares of Company stock on July 1, 2021 at prices ranging from $562.00 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 16 shares of Company stock on July 1, 2021 at prices ranging from $563.03 to $563.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 6 shares of Company stock on July 1, 2021 at prices ranging from $564.26 to $564.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $565.00 to $565.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 12 shares of Company stock on July 1, 2021 at prices ranging from $566.09 to $566.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $567.15 to $567.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $568.10 to $568.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.